Centralspindlin-mediated transport of RhoGEF positions the ... - Science
| 291650 Stock | KRW 1,750 110.00 5.91% |
About 62% of Aptamer Sciences' investor base is looking to short. The analysis of current outlook of investing in Aptamer Sciences suggests that many traders are alarmed regarding Aptamer Sciences' prospects. The current market sentiment, together with Aptamer Sciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Aptamer Sciences stock news signals to limit their universe of possible portfolio assets.
Aptamer |
Centralspindlin-mediated transport of RhoGEF positions the ... Science
Read at news.google.com
 |
Aptamer Sciences Fundamental Analysis
We analyze Aptamer Sciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aptamer Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aptamer Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Aptamer Sciences is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Aptamer Sciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aptamer Sciences stock to make a market-neutral strategy. Peer analysis of Aptamer Sciences could also be used in its relative valuation, which is a method of valuing Aptamer Sciences by comparing valuation metrics with similar companies.
Peers
Aptamer Sciences Related Equities
| 000660 | SK Hynix | 0.74 |
| ||
| 005385 | Hyundai | 0.95 |
| ||
| 005387 | Hyundai | 1.78 |
| ||
| 005930 | Samsung Electronics | 2.34 |
| ||
| 207940 | Samsung Biologics | 2.50 |
| ||
| 005935 | Samsung Electronics | 3.25 |
| ||
| 373220 | LG Energy | 5.22 |
| ||
| 006400 | Samsung SDI | 6.43 |
| ||
| 051915 | LG Chem | 6.63 |
| ||
| 051910 | LG Chemicals | 6.89 |
|
Complementary Tools for Aptamer Stock analysis
When running Aptamer Sciences' price analysis, check to measure Aptamer Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aptamer Sciences is operating at the current time. Most of Aptamer Sciences' value examination focuses on studying past and present price action to predict the probability of Aptamer Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aptamer Sciences' price. Additionally, you may evaluate how the addition of Aptamer Sciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |